BIOMAT Database Logo BIOMAT Database Logo

Neonatal screening for dihydropteridine reductase deficiency. 1985

A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D009247 NADH, NADPH Oxidoreductases A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. Oxidoreductases, NADH, NADPH,NADPH Oxidoreductases NADH,Oxidoreductases NADH, NADPH
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D004093 Dihydropteridine Reductase An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7. 6,7-Dihydropteridine Reductase,6,7 Dihydropteridine Reductase,Reductase, 6,7-Dihydropteridine,Reductase, Dihydropteridine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Tetrahydrobiopterin in dihydropteridine reductase deficiency.
February 1986, The New England journal of medicine,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Molecular basis of dihydropteridine reductase deficiency.
January 1995, Human mutation,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Transdermal rotigotine in dihydropteridine reductase deficiency.
August 2016, Journal of the neurological sciences,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
[Malignant hyperphenylalaninemia with dihydropteridine reductase deficiency].
November 1986, Ceskoslovenska pediatrie,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Intracranial calcification in dihydropteridine reductase deficiency.
January 1990, The Turkish journal of pediatrics,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Two mutations of dihydropteridine reductase deficiency.
February 1988, Archives of disease in childhood,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.
September 1978, European journal of pediatrics,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Dopamine agonists in dihydropteridine reductase deficiency.
April 2012, Molecular genetics and metabolism,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Genotype-phenotype correlation in dihydropteridine reductase deficiency.
June 2000, Journal of inherited metabolic disease,
A Sahota, and J A Blair, and P A Barford, and R J Leeming, and A Green, and R J Pollitt
Cranial computerized tomography in dihydropteridine reductase deficiency.
January 1985, Journal of inherited metabolic disease,
Copied contents to your clipboard!